Description

Description

Tagipmet XR (50mg/500mg) is a fixed-dose combination medicine manufactured by Highnoon Laboratories, formulated with Sitagliptin 50mg and extended-release Metformin 500mg in each tablet. This pack contains 20 tablets and is designed for adults with type 2 diabetes mellitus who benefit from a once-daily dosing pattern made possible by the extended-release technology of the Metformin component. Unlike standard immediate-release Metformin, the XR formulation is designed to release the medicine gradually over an extended period, which may help reduce the frequency of gastrointestinal side effects and offer more consistent blood sugar control throughout the day. Sitagliptin works by increasing levels of natural hormones that prompt the pancreas to release more insulin when blood sugar is high while also reducing glucose production by the liver, and it carries a relatively gentle safety profile with a lower likelihood of causing significant drops in blood sugar on its own. Metformin complements this by reducing hepatic glucose output and improving the body’s sensitivity to insulin. Together, this combination is intended to provide comprehensive glycemic support in a more convenient, less frequent dosing schedule. As with all diabetes medications, Tagipmet XR should be used as part of a complete management plan involving proper diet, regular physical activity, and consistent blood sugar monitoring, and only under the continued supervision of a qualified healthcare provider.

Ingredients

Each tablet of Tagipmet XR (50/500mg) contains two active pharmaceutical ingredients: Sitagliptin 50mg, a DPP-4 inhibitor that supports insulin release and reduces liver glucose production, and Metformin Hydrochloride 500mg in extended-release form, a biguanide-class antidiabetic agent that reduces hepatic glucose output and enhances insulin sensitivity. The tablet also contains specialized extended-release excipients and film-coating agents that control the gradual release of Metformin over time, along with standard binding agents that support the tablet’s overall structural integrity.

Dosage Form

Tagipmet XR (50/500mg) is available as an oral extended-release film-coated tablet, delivering a combined strength of 50mg Sitagliptin and 500mg extended-release Metformin per tablet. The pack contains 20 tablets, formulated for once-daily administration as directed by a treating physician.

Uses

Tagipmet XR (50/500mg) is used to help improve blood sugar control in adults with type 2 diabetes mellitus, particularly for those who benefit from the smoother glucose control and reduced dosing frequency offered by extended-release Metformin, combined with the added glucose-lowering effect of Sitagliptin. It is often preferred for patients who experience gastrointestinal discomfort with immediate-release Metformin or who prefer a simplified once-daily regimen. It may also be used in conjunction with other antidiabetic therapies as directed by a physician. This medicine is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.

How to Use

Tagipmet XR tablets are typically taken once daily with the evening meal, or as otherwise directed by a doctor, to support optimal absorption and reduce gastrointestinal discomfort. The tablet must be swallowed whole with a glass of water and should never be crushed, split, or chewed, as doing so can disrupt the extended-release mechanism and cause the medicine to be released too quickly. Patients may occasionally notice a tablet-shaped residue in their stool, which is a normal part of the extended-release delivery system and does not indicate that the medicine was not absorbed. Dosage and duration of treatment should strictly follow the prescribing physician’s instructions, and if a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next dose, in which case the missed dose should be skipped rather than doubled.

Side Effects

Tagipmet XR (50/500mg) may cause side effects in some individuals, although the extended-release formulation is often associated with a lower incidence of gastrointestinal discomfort compared to immediate-release versions. Commonly reported effects still include nausea, mild diarrhea, or stomach discomfort, particularly when treatment is first started, along with headache and upper respiratory symptoms associated with the Sitagliptin component. Some patients may also experience a metallic taste or mild dizziness. In rare cases, more serious effects such as lactic acidosis (associated with Metformin), pancreatitis, or severe allergic reactions (associated with Sitagliptin) may occur, and immediate medical attention should be sought if symptoms such as severe abdominal pain, unusual fatigue, difficulty breathing, or persistent vomiting develop.

Pregnancy & Breastfeeding

Tagipmet XR (50/500mg) is generally not recommended during pregnancy. While Metformin has been used in select pregnancy-related situations under close medical supervision, the safety of Sitagliptin during pregnancy has not been well established, and insulin is typically preferred for blood sugar management during this period. Women who are pregnant, planning pregnancy, or suspect they may be pregnant should inform their doctor immediately. The safety of this combination during breastfeeding has not been well established, and alternative treatment options are usually considered for nursing mothers. Any use during pregnancy or breastfeeding should be decided only in consultation with a qualified healthcare provider.

Storage Instructions

Tagipmet XR tablets should be stored at room temperature, in a cool, dry place away from direct sunlight, heat, and excess moisture. Tablets should be kept in their original packaging until ready for use to protect the extended-release coating from environmental exposure. Store out of reach of children and pets, and do not use the medication beyond its printed expiry date. Unused or expired tablets should be disposed of responsibly according to local pharmaceutical disposal guidelines, rather than discarded with regular household waste.

FAQs

What does “XR” mean in Tagipmet XR?
XR stands for extended-release, referring to the Metformin component’s gradual release mechanism, which allows for once-daily dosing and may reduce gastrointestinal side effects.

Why shouldn’t I crush or split this tablet?
Crushing or splitting disrupts the extended-release coating, causing the medicine to be released too quickly, which can increase the risk of side effects and reduce its intended smooth action.

Is it normal to see something resembling the tablet in my stool?
Yes, this can happen with extended-release tablets and is a normal part of how the outer shell passes through the digestive system after the medicine has been absorbed.

Can I take Tagipmet XR at a different time of day if needed?
It is best to take it at a consistent time each day, ideally with the evening meal, but any changes to timing should be discussed with your doctor.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.